Tomeglovir is a potent anti-CMVagent, inhibiting processing of viral DNA-concatemers, withIC₅₀s of 0.34 μM and 0.039 μM for HCMV and MCMV.

IC50: 0.34 μM (HCMV), 0.039 μM (MCMV)^[1]

Tomeglovir (BAY 38-4766) is a potent anti-CMV agent, with IC₅₀s of 0.34 μM and 0.039 μM for HCMV and MCMV. Tomeglovir also suppresses HELF and NIH 3T3 cells, with CC₅₀s of 85 μM and 62.5 μM, respectively^[1]. Tomeglovir (BAY 38-4766) inhibits HCMV Davis and various monkey CMV strains with EC₅₀s of 1.03 ± 0.57 μM and< 1 μM^[2].

Tomeglovir (BAY 38-4766; 3, 10, 30, 100 mg/kg, p.o.) dose-dependently reduces MCMV-DNA in salivary glands, livers and kidneys of MCMV-infected NOD-SCID mice, and prolongs the survival of the mice. Tomeglovir (10, 25 and 50 mg/kg) shows antiviral activity in the hollow fiber mouse model^[1]. Tomeglovir (BAY 38-4766) shows antiviral activity in SCID mice with MCMV, and the LD₅₀is >2000 mg/kg in mice and rats^[2].

441.54

Solid

C₂₃H₂₇N₃O₄S

233254-24-5

托美洛韦

Room temperature in continental US; may vary elsewhere.

DMSO : ≥ 108 mg/mL(244.60 mM)

*"≥" means soluble, but saturation unknown.

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。